The Biomaterials and Advanced Drug Delivery (Division of CVI)
The Biomaterials and Advanced Drug Delivery (BioADD) Laboratory is a cutting edge research lab of Stanford Cardiovascular Institute in Stanford University School of Medicine. Today’s problems in drug design require complex answers to achieve effective delivery and treatment. The Stanford BioADD Lab/Rajadas Lab helps to solve these problems with advanced modern technology and innovative solutions. Specializing in the creation of biomaterials and drug delivery agents, the lab lends its expertise toward designing and analyzing biomaterials, developing drug delivery devices and formulations, pharmacokinetic and pharmacodynamic studies, and developing smart materials for biomedical applications.
Why are Alzheimer's drug developers getting the blues? It depends on what's meant by "getting the blues."
The field has been plagued by a succession of failures of one experimental drug after another, Stanford drug researcher Jay Rajadas, PhD, tells me, with promising effects shown in early clinical trials disappearing like mist in the morning in crucial large-scale late trials. In response, big pharmaceutical companies have gradually abandoned their onetime obsession with ridding Alzheimer’s patients’ brains of gummy extracellular deposits known as amyloid plaques. . .